Mark A. Frye

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression

Xianlin Han, A. Rush, M. Frye, 2020, bioRxiv.

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients

A. Rush, M. Frye, R. Weinshilboum, 2019, Translational Psychiatry.

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects

M. Frye, R. Weinshilboum, J. Biernacka, 2015, Translational Psychiatry.